KRONOS BIO INC. - COM

0,9601

27-ноября-24 15:45:00

15 мин. задержка

Акции

+0,0951

+10,99%

Сегодняшний диапазон

0,9200 - 0,9899

ISIN

N/A

Источник

NASDAQ

Kronos Bio Announces Positive End-of-Phase 2 Meeting with FDA for Entospletinib in Newly Diagnosed NPM1-mutated Acute Myeloid Leukemia (AML)

04 мар 2021 06:00:01 Источник Nasdaq GlobeNewswire
Kronos Bio Announces First Patient Dosed in Phase 1/2 Clinical Trial of KB-0742, an Oral CDK9 Inhibitor Targeting MYC-amplified Cancers

25 фев 2021 07:00:01 Источник Nasdaq GlobeNewswire
Kronos Bio Appoints Marianne De Backer, Ph.D., to Board of Directors

26 янв 2021 07:00:02 Источник Nasdaq GlobeNewswire

<<
<
1
2
3
4
5
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.